Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20485-38-5

Post Buying Request

20485-38-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20485-38-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 20485-38-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,4,8 and 5 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 20485-38:
(7*2)+(6*0)+(5*4)+(4*8)+(3*5)+(2*3)+(1*8)=95
95 % 10 = 5
So 20485-38-5 is a valid CAS Registry Number.

20485-38-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(4-aminophenoxy)acetate

1.2 Other means of identification

Product number -
Other names ethyl (4-aminophenoxy)-acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20485-38-5 SDS

20485-38-5Relevant articles and documents

Synthesis, molecular docking, dynamic simulation and pharmacological characterization of potent multifunctional agent (dual GPR40-PPARγ agonist) for the treatment of experimental type 2 diabetes

Hidalgo-Figueroa, Sergio,Rodríguez-Luévano, Ana,Almanza-Pérez, Julio C.,Giacoman-Martínez, Abraham,Ortiz-Andrade, Rolffy,León-Rivera, Ismael,Navarrete-Vázquez, Gabriel

, (2021/06/18)

The current manuscript describes two molecules that were designed against PPARγ and GPR40 receptors. The preparation of the compounds was carried out following a synthetic route of multiple steps. Then, the mRNA expression levels of PPARγ, GLUT4, and GPR4

Pyrazolo[3,4-c]pyridine derivative

-

Paragraph 0367; 0368; 0369, (2016/10/08)

The invention relates to a pyrazolo[3,4-c]pyridine derivative. The invention relates to a compound represented by a formula (I), a tautomer thereof, an optical isomer thereof or a pharmaceutically acceptable salt thereof, wherein the formula (I) is shown in the description, and Z, X, RNc, RNd, RNe and RNf are defined according to the claim 1. The invention further relates to the pharmaceutical composition contain the compound. The invention further relates to use of the compound or the pharmaceutical composition in preparing a drug for preventing and/or treating a disease which inhibits positive influence of an Xa factor, particularly use in preparing the drug for preventing and/or treating the disease which inhibits positive influence of the Xa factor under the condition of low hemorrhage risk.

HETEROARYL COMPOUNDS AND USES THEREOF

-

Paragraph 0674, (2015/07/02)

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20485-38-5